๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Botulinum Toxin Type A - Medicines in Ireland

8 authorised products containing Botulinum Toxin Type A, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 8 authorised medicines
MedicineActive substanceLicence holderStatus
BOTOX 100 Allergan Units powder for solution for injection
PA1824/017/001
Botulinum Toxin Type A AbbVie Limited Marketed
BOTOX 100 Allergan Units powder for solution for injection
PPA0465/521/001
Botulinum toxin type A PCO Manufacturing Ltd. โ€”
BOTOX 200 Allergan Units powder for solution for injection
PA1824/017/003
Botulinum Toxin Type A AbbVie Limited Marketed
BOTOX 50 Allergan Units powder for solution for injection
PA1824/017/002
Botulinum Toxin Type A AbbVie Limited Marketed
Nuceiva 100 U Powder for solution for injection
EU/1/19/1364/001
Botulinum Toxin Type A Evolus Pharma Ltd. โ€”
Nuceiva 50 U Powder for solution for injection
EU/1/19/1364/002
Botulinum Toxin Type A Evolus Pharma Ltd. โ€”
Relfydess, 100 units/mL, solution for injection
PA1613/005/001
Botulinum Toxin Type A Ipsen Pharma Marketed
VISTABEL, 4 Allergan Units/0.1ml, Powder for solution for injection
PA1824/020/001
Botulinum Toxin Type A AbbVie Limited Marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.